Observational studyDer Urologe. Ausg. A2021

[Active surveillance-much safety, little recruitment : Is it possible to extend the indication for "intermediate-risk" prostate cancer?]

Lothar Weißbach et al.PubMed ↗Publisher ↗

No numbers read from the abstract.